Contrave Weight Loss Medicine

Weight Loss Drug Contrave Now Approved by FDA

Contrave Weight Loss MedicineThe Food and Drug Administration (FDA) has finally approved the weight loss drug Contrave.

The approval has been a long awaited outcome. When an FDA advisory panel voted to recommend the drug in December 2010, FDA approval was expected to follow. Instead, the FDA rejected the drug in February 2011, with a request for additional studies to determine whether or not the benefits of using the weight loss drug outweighed the cardiovascular side effects.

The study results were submitted in November 2013. The decision was finally announced this month granting approval. It is expected to be available sometime later in the fall of this year for patients with a prescription.

(more…)

Read More

Orexigen Therapeutics Weight Loss Drug Contrave

Weight Loss Drug Contrave Rejected by FDA

Orexigen TherapeuticsThe FDA ruled against approving the weight loss drug Contrave in a decision that surprised many. A positive vote was expected, since an advisory panel had recommended approving the drug by a vote of 13-to-7 in December.

As this decision shows, the FDA is not required to follow the advice of its expert panels. Rather, the FDA requested additional clinical trials to determine whether or not the benefits of using the weight loss drug outweighed the cardiovascular side effects.

(more…)

Read More

Contrave Obesity Drug

Orexigen Asks FDA for Approval of Contrave Weight Loss Drug

Contrave Obesity DrugFollowing successful results in clinical trials with its potential weight loss drug Contrave, Orexigen Therapeutics has taken the next step for market approval and submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA).

Contrave is now one of several obesity drugs that are currently awaiting FDA approval. Rather than affecting food digestion and blocking fat absorption, Contrave acts on the central nervous system to reduce hunger, increase energy expenditure, and negatively alter the palpability of sweets.

If approval of the NDA is granted, the company will legally be able to sell and market Contrave in the United States as a weight loss therapy, although consumer use will require a prescription from a medical professional.

(more…)

Read More